Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon K Chen

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|March 5, 2016
The determination of the DNA sequence specificity of bleomycin-induced abasic sitesJon K Chen, Vincent Murray
International Journal of Molecular Sciences|May 9, 2018
The Interaction of the Metallo-Glycopeptide Anti-Tumour Drug Bleomycin with DNAVincent Murray, Jon K Chen, Long H Chung
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|May 17, 2017
The DNA sequence specificity of bleomycin cleavage in a systematically altered DNA sequenceShweta D Gautam, Jon K Chen, Vincent Murray
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 2, 2013
Bleomycin DNA damage: Anomalous mobility of 3'-phosphoglycolate termini in an automated capillary DNA sequencerTrung V Nguyen, Jon K Chen, Vincent Murray
Molecular Biology Reports|May 19, 2016
The genome-wide DNA sequence specificity of the anti-tumour drug bleomycin in human cellsVincent Murray, Jon K Chen, Mark M Tanaka
Chemical Biology & Drug Design|March 16, 2012
The use of automated sequencing techniques to investigate the sequence selectivity of DNA-damaging agentsVincent Murray, Trung V Nguyen, Jon K Chen
Cellular and Molecular Life Sciences : CMLS|August 29, 2013
The anti-tumor drug bleomycin preferentially cleaves at the transcription start sites of actively transcribed genes in human cellsVincent Murray, Jon K Chen, Anne M Galea
Mutation Research|March 17, 2015
Enhanced DNA repair of bleomycin-induced 3'-phosphoglycolate termini at the transcription start sites of actively transcribed genes in human cellsVincent Murray, Jon K Chen, Anne M Galea
Bioorganic & Medicinal Chemistry|July 15, 2018
The genome-wide sequence specificity of DNA cleavage by bleomycin analogues in human cellsVincent Murray, Jon K Chen, Dong Yang, et al.
The International Journal of Biochemistry & Cell Biology|February 8, 2017
Bleomycin analogues preferentially cleave at the transcription start sites of actively transcribed genes in human cellsJon K Chen, Dong Yang, Ben Shen, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|March 5, 2016
The determination of the DNA sequence specificity of bleomycin-induced abasic sitesJon K Chen, Vincent Murray
International Journal of Molecular Sciences|May 9, 2018
The Interaction of the Metallo-Glycopeptide Anti-Tumour Drug Bleomycin with DNAVincent Murray, Jon K Chen, Long H Chung
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|May 17, 2017
The DNA sequence specificity of bleomycin cleavage in a systematically altered DNA sequenceShweta D Gautam, Jon K Chen, Vincent Murray
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 2, 2013
Bleomycin DNA damage: Anomalous mobility of 3'-phosphoglycolate termini in an automated capillary DNA sequencerTrung V Nguyen, Jon K Chen, Vincent Murray
Molecular Biology Reports|May 19, 2016
The genome-wide DNA sequence specificity of the anti-tumour drug bleomycin in human cellsVincent Murray, Jon K Chen, Mark M Tanaka
Chemical Biology & Drug Design|March 16, 2012
The use of automated sequencing techniques to investigate the sequence selectivity of DNA-damaging agentsVincent Murray, Trung V Nguyen, Jon K Chen
Cellular and Molecular Life Sciences : CMLS|August 29, 2013
The anti-tumor drug bleomycin preferentially cleaves at the transcription start sites of actively transcribed genes in human cellsVincent Murray, Jon K Chen, Anne M Galea
Mutation Research|March 17, 2015
Enhanced DNA repair of bleomycin-induced 3'-phosphoglycolate termini at the transcription start sites of actively transcribed genes in human cellsVincent Murray, Jon K Chen, Anne M Galea
Bioorganic & Medicinal Chemistry|July 15, 2018
The genome-wide sequence specificity of DNA cleavage by bleomycin analogues in human cellsVincent Murray, Jon K Chen, Dong Yang, et al.
The International Journal of Biochemistry & Cell Biology|February 8, 2017
Bleomycin analogues preferentially cleave at the transcription start sites of actively transcribed genes in human cellsJon K Chen, Dong Yang, Ben Shen, et al.
Pageof 2